Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Spironolactone Normalize Sleep-wake Luteinizing Hormone (LH) Pulse Frequency in Pubertal Girls With Hyperandrogenism? (CBS010)

NCT04723862 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT04723862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04723862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Spironolactone Normalize Sleep-wake Luteinizing Hormone (LH) Pulse Frequency in Pubertal Girls With Hyperandrogenism? (CBS010)
Lead sponsor
University of Virginia
Phase
Phase 1
Overall status
Recruiting
Start date
November 12, 2021
Completion date
December 1, 2025
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperandrogenism, polycystic ovary syndrome, puberty